
A randomized trial found a FORTA-based, pharmacist-led medication review sharply reduced inappropriate prescribing, overuse and underuse among older cancer patients with polypharmacy.
Medical Economics surveyed more than 1,000 physicians and asked them what issues they feel are ruining the practice of medicine.




